Skip to main content

MoneyWorks4Me

Zydus Lifesciences informs about press release

08 Apr 2026 Evaluate
Zydus Lifesciences has informed that it enclosed a copy of press release dated April 8, 2026, titled ‘Zydus receives final approval from USFDA for Dapagliflozin Tablets, 5 mg and 10 mg’.

The above information is a part of company’s filings submitted to BSE. 
Peers
Company Name CMP
Sun Pharma. Inds. 1915.10
Dr. Reddys Labs. 1369.00
Cipla 1410.95
Lupin 1995.00
Zydus Lifesciences 1200.00
View more..